Michelle  Brennan net worth and biography

Michelle Brennan Biography and Net Worth

Director of Cardinal Health
Global Value Creation Leader of Johnson & Johnson, a researcher, developer, and manufacturer in the healthcare and consumer packaged goods fields, from 2019 to 2020 and Company Group Chair of Medical Devices in Europe, the Middle East, and Africa, from 2015 to 2018

Prior public company directorships within the last five years: Coupa Software Incorporated, a global technology platform for Business Spend Management, from 2020 until 2023

What is Michelle Brennan's net worth?

The estimated net worth of Michelle Brennan is at least $301,756.80 as of November 10th, 2022. Ms. Brennan owns 2,924 shares of Cardinal Health stock worth more than $301,757 as of April 27th. This net worth approximation does not reflect any other investments that Ms. Brennan may own. Learn More about Michelle Brennan's net worth.

How do I contact Michelle Brennan?

The corporate mailing address for Ms. Brennan and other Cardinal Health executives is 7000 CARDINAL PLACE, DUBLIN OH, 43017. Cardinal Health can also be reached via phone at (614) 757-5000 and via email at [email protected]. Learn More on Michelle Brennan's contact information.

Has Michelle Brennan been buying or selling shares of Cardinal Health?

Michelle Brennan has not been actively trading shares of Cardinal Health during the last ninety days. Most recently, on Thursday, November 10th, Michelle Brennan bought 150 shares of Cardinal Health stock. The stock was acquired at an average cost of $79.74 per share, with a total value of $11,961.00. Following the completion of the transaction, the director now directly owns 2,924 shares of the company's stock, valued at $233,159.76. Learn More on Michelle Brennan's trading history.

Who are Cardinal Health's active insiders?

Cardinal Health's insider roster includes Michelle Brennan (Director), Stephen Mason (CEO), Jessica Mayer (Insider), Ola Snow (Insider), and Deborah Weitzman (CEO). Learn More on Cardinal Health's active insiders.

Are insiders buying or selling shares of Cardinal Health?

In the last year, insiders at the sold shares 5 times. They sold a total of 131,694 shares worth more than $12,296,445.19. The most recent insider tranaction occured on November, 27th when CEO Deborah Weitzman sold 36,642 shares worth more than $3,895,411.02. Insiders at Cardinal Health own 0.2% of the company. Learn More about insider trades at Cardinal Health.

Information on this page was last updated on 11/27/2023.

Michelle Brennan Insider Trading History at Cardinal Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/10/2022Buy150$79.74$11,961.002,924View SEC Filing Icon  
See Full Table

Michelle Brennan Buying and Selling Activity at Cardinal Health

This chart shows Michelle Brennan's buying and selling at Cardinal Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cardinal Health Company Overview

Cardinal Health logo
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Read More

Today's Range

Now: $103.20
Low: $102.94
High: $103.94

50 Day Range

MA: $109.51
Low: $102.83
High: $115.62

2 Week Range

Now: $103.20
Low: $77.56
High: $116.04

Volume

1,399,895 shs

Average Volume

2,255,536 shs

Market Capitalization

$25.10 billion

P/E Ratio

40.63

Dividend Yield

1.93%

Beta

0.68